Dyne Therapeutics Inc Capital Reinvestment Ratio
Dyne Therapeutics Inc capital reinvestment ratio. Dyne Therapeutics Inc (DYN) has a Capital Reinvestment Ratio of 2.67x as of December 2017, meaning it reinvests 3% of its operating cash flow ($84.00 Million) in capital expenditures ($224.00 Million). See DYN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Dyne Therapeutics Inc (2010–2017)
Capital reinvestment ratio of Dyne Therapeutics Inc from 2010 to 2017. This chart tracks Dyne Therapeutics Inc's Capital Reinvestment Ratio across 5 annual periods. See DYN financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Dyne Therapeutics Inc Capital Reinvestment Ratio by Year (2010–2017)
Dyne Therapeutics Inc capital reinvestment ratio by year from 2010 to 2017. For the full cash flow conversion analysis, see DYN cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.38x | $585.00 Million | $224.00 Million | ▼ -20.6% |
| 2016 | 0.48x | $676.00 Million | $326.00 Million | ▼ -83.5% |
| 2015 | 2.93x | $94.00 Million | $275.00 Million | ▲ +422.4% |
| 2013 | 0.56x | $175.00 Million | $98.00 Million | ▼ -28.9% |
| 2010 | 0.79x | $423.00 Million | $333.00 Million | — |